title: Treatment of recalcitrant vulvovaginal gingival syndrome with adalimumab.
authors.affiliation: Stanford University School of Medicine, Stanford, California.
authors.forename: Joyce K
authors.initials: JK
authors.lastname: Ho
authors.affiliation: Elixir Institute of Regenerative Medicine, San Jose, California. Electronic address: basil@elixirinstitute.org.
authors.forename: Basil M
authors.initials: BM
authors.lastname: Hantash
mesh_terms: D000068879:Adalimumab; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D002908:Chronic Disease; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D005891:Gingivitis / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D012720:Severity of Illness Index; D013577:Syndrome; D016896:Treatment Outcome; D014627:Vaginitis / Q000175:diagnosis / Q000188:drug therapy*; D014847:Vulvitis / Q000175:diagnosis / Q000188:drug therapy*
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068879:Adalimumab